Regentis Biomaterials Ltd. (RGNT) — Cash Flow Quality Index

Latest as of December 2024: -0.13x

Regentis Biomaterials Ltd. (RGNT) has a Cash Flow Quality Index of -0.13x as of December 2024. Operating cash flow of $-641.00K is below net income of $4.80 Million, suggesting accrual-heavy earnings not yet converted to cash. For the full cash flow conversion analysis, see Regentis Biomaterials Ltd. cash conversion from operations.

Cash Flow Quality Index

-0.13x
Operating CF / Net Income

Operating Cash Flow

$-641.00K
USD

Net Income

$4.80 Million
USD

Data as of

Dec 2024
Most recent filing

Regentis Biomaterials Ltd. Cash Flow Quality Index (2024–2024)

Historical Cash Flow Quality Index for Regentis Biomaterials Ltd. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Regentis Biomaterials Ltd. to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Quality Index for Regentis Biomaterials Ltd. (2024–2024)

Year-by-year earnings quality comparison for Regentis Biomaterials Ltd.. See Regentis Biomaterials Ltd. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Year Quality Index Operating CF (USD) Net Income YoY Change
2024 -0.13x $-641.00K $4.80 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.